Loading clinical trials...
Loading clinical trials...
In the current practice patients with normal levels of ALT were not treated. However, a percentage of patients will present an advanced grade of fibrosis and cirrhosis. Another reason to treat is the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Miguel Santin
NCT06180590 · Chronic Hepatitis C, Medication Reaction
NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage
NCT00199719 · Chronic Hepatitis C
NCT06922643 · Chronic Hepatitis C
NCT01340573 · Chronic Hepatitis C
Hospital de Txagorritxu
Vitoria-Gasteiz, Alava
Hospital del Mar
Barcelona, Barcelona
Hospital Santa Creu i Sant Pau
Barcelona, Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions